HighVista Strategies’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-25,300
Closed -$50K 106
2020
Q1
$50K Sell
25,300
-4,900
-16% -$9.68K 0.05% 44
2019
Q4
$86K Buy
30,200
+12,000
+66% +$34.2K 0.07% 88
2019
Q3
$67K Buy
+18,200
New +$67K 0.05% 98